Literature DB >> 7606223

A theoretical explanation of "concomitant resistance".

S Michelson1, J T Leith.   

Abstract

Concomitant resistance is a tumor growth dynamic which results when the growth of a second tumor implant is inhibited by the presence of the first. Recently, we modeled tumor growth in the presence of a regenerating liver after partial hepatectomy (Michelson and Leith, Bull. Math. Biol. 57, 345-366, 1995), with an interlocking pair of growth control triads to account for the accelerated growth observed in both tissues. We also modeled tumor dormancy and recurrence as a dynamic equilibrium achieved between proliferating and quiescent subpopulations. In this paper those studies are extended to initially model the concomitant resistance case. Two interlocking model systems are proposed. In one an interactive competition between the tumor implants is described, while in the other purely proportional growth inhibition is described. The equilibria and dynamics of each system when the coefficients are held constant are presented for three subcases of model parameters. We show that the dynamic called concomitant resistance can be real or apparent, and that if the model coefficients are held constant, the only way to truly achieve concomitant resistance is by forcing one of the tumors into total quiescence. If this is the true state of the inhibited implant, then a non-constant recruitment signal is required to insure regrowth when the inhibitor mass is excised. We compare these theoretical results to a potential explanation of the phenomenon provided by Prehn (Cancer Res. 53, 3266-3269, 1993).

Entities:  

Mesh:

Year:  1995        PMID: 7606223

Source DB:  PubMed          Journal:  Bull Math Biol        ISSN: 0092-8240            Impact factor:   1.758


  16 in total

1.  Tumor growth in partially hepatectomized rats.

Authors:  K E PASCHKIS; A CANTAROW; J STASNEY; J H HOBBS
Journal:  Cancer Res       Date:  1955-10       Impact factor: 12.701

2.  A nonlinear structured population model of tumor growth with quiescence.

Authors:  M Gyllenberg; G F Webb
Journal:  J Math Biol       Date:  1990       Impact factor: 2.259

3.  The enhancement of tumor growth after partial hepatectomy and the effect of sera obtained from hepatectomized rats on tumor cell growth.

Authors:  T Asaga; K Suzuki; M Umeda; Y Sugimasa; S Takemiya; T Okamoto
Journal:  Jpn J Surg       Date:  1991-11

Review 4.  The inhibition of tumor growth by tumor mass.

Authors:  R T Prehn
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

5.  Type beta transforming growth factor: a bifunctional regulator of cellular growth.

Authors:  A B Roberts; M A Anzano; L M Wakefield; N S Roche; D F Stern; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

Review 6.  Concomitant tumor immunity and the resistance to a second tumor challenge.

Authors:  E Gorelik
Journal:  Adv Cancer Res       Date:  1983       Impact factor: 6.242

7.  Dormancy, regression, and recurrence: towards a unifying theory of tumor growth control.

Authors:  S Michelson; J T Leith
Journal:  J Theor Biol       Date:  1994-08-21       Impact factor: 2.691

8.  Interlocking triads of growth control in tumors.

Authors:  S Michelson; J T Leith
Journal:  Bull Math Biol       Date:  1995-03       Impact factor: 1.758

9.  Autocrine and paracrine growth factors in tumor growth: a mathematical model.

Authors:  S Michelson; J Leith
Journal:  Bull Math Biol       Date:  1991       Impact factor: 1.758

10.  "Concomitant immunity" in murine tumours of non-detectable immunogenicity.

Authors:  R A Ruggiero; O D Bustuoabad; R D Bonfil; R P Meiss; C D Pasqualini
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

View more
  1 in total

1.  Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasis.

Authors:  Geraldine Gueron; Nicolás Anselmino; Paula Chiarella; Emiliano G Ortiz; Sofia Lage Vickers; Alejandra V Paez; Jimena Giudice; Mario D Contin; Daiana Leonardi; Felipe Jaworski; Verónica Manzano; Ariel Strazza; Daniela R Montagna; Estefania Labanca; Javier Cotignola; Norma D Accorso; Anna Woloszynska-Read; Nora Navone; Roberto P Meiss; Raúl Ruggiero; Elba Vazquez
Journal:  Cell Death Dis       Date:  2018-02-02       Impact factor: 8.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.